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Abstract
Background: Psychological therapies provided in primary care are usually briefer than in secondary care. There has 
been no recent comprehensive review comparing their effectiveness for common mental health problems. We aimed 
to compare the effectiveness of different types of brief psychological therapy administered within primary care across 
and between anxiety, depressive and mixed disorders.
Methods: Meta-analysis and meta-regression of randomized controlled trials of brief psychological therapies of adult 
patients with anxiety, depression or mixed common mental health problems treated in primary care compared to 
primary care treatment as usual.
Results: Thirty-four studies, involving 3962 patients, were included. Most were of brief cognitive behaviour therapy 
(CBT; n = 13), counselling (n = 8) or problem solving therapy (PST; n = 12). There was differential effectiveness between 
studies of CBT, with studies of CBT for anxiety disorders having a pooled effect size [d -1.06, 95% confidence interval (CI) 
-1.31 to -0.80] greater than that of studies of CBT for depression (d -0.33, 95% CI -0.60 to -0.06) or studies of CBT for 
mixed anxiety and depression (d -0.26, 95% CI -0.44 to -0.08). Counselling for depression and mixed anxiety and 
depression (d -0.32, 95% CI -0.52 to -0.11) and problem solving therapy (PST) for depression and mixed anxiety and 
depression (d -0.21, 95% CI -0.37 to -0.05) were also effective. Controlling for diagnosis, meta-regression found no 
difference between CBT, counselling and PST.
Conclusions: Brief CBT, counselling and PST are all effective treatments in primary care, but effect sizes are low 
compared to longer length treatments. The exception is brief CBT for anxiety, which has comparable effect sizes.
Background
Anxiety and depressive disorders are common, with esti-
mated combined prevalence varying between countries
but over 10% in most Western countries [1-4]. The
majority of such patients are treated in primary care, with
few patients referred on to secondary mental health ser-
vices [5,6].
With access to psychological therapies being limited
[7], psychological therapy provided within primary care
settings for depression and anxiety is usually brief [8]. In
the UK, six sessions is a common treatment length [9].
This contrasts to the treatment lengths of 12 - 24 sessions
which have been the subject of most efficacy trials of psy-
chological therapies in secondary care settings [10,11].
Most reviews of psychological therapies combine pri-
mary and secondary care studies [11-13]. Recent reviews
which have included analyses limited to primary care,
have focussed on studies of patients with a diagnosis of
depression [14-18] or studies of a specific type of psycho-
logical therapy [19]. Although studies of psychological
therapies in primary care frequently include patients with
both anxiety and depression, reflecting the heteroge-
neous patient presentations in primary care where mixed
anxiety and depression is the most common diagnosis
[20-22], such studies are excluded when the selection cri-
teria for reviews are limited to single mental health diag-
noses. The only reviews covering the range of mental
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health disorders and types of psychological therapies
used within primary care date back over a decade [23-26].
This systematic review, meta-analysis and meta-regres-
sion includes studies of anxiety, depression and mixed
common mental health problems. It compares the effec-
tiveness of different types of brief psychological therapies
within primary care across and between disorders com-
pared to treatment as usual. In the absence of studies
directly comparing different types of psychological ther-
apy provided in primary care (with one exception [27]),
such comparisons are needed to help inform decisions
about treatment.
Methods
Search strategy
Studies were identified as part of a broader search of
intervention studies in primary care mental health. The
Medline, Embase and Psycinfo databases from inception
to July 2008 were searched using a sensitive search strat-
egy involving combinations of 'mental health' ('mental
health' or psychol* or anx* or depress* or schizo* or dys-
thymi* or psychiatr* or emotion* or counsel*) and 'pri-
mary care' terms ('primary care' or 'primary health care'
or 'family physician*' or 'practice nurs*' or 'general pract*'
or GP*) in order to maximize identification of relevant
interventions. Additional papers were identified from ref-
erence lists, from hand searching key journals and from
contact with other primary care mental health research-
ers. All searches were limited to peer-reviewed published
works in English.
Inclusion criteria
For this review, we included published randomized con-
trolled trials of brief psychological therapies for adult
patients with anxiety, depression, unspecified common
mental health problems or 'emotional distress' provided
by someone other than the patient's general practitioner
(GP) either in primary care or at home organized from
primary care. 'Brief' was operationalized as more than
two and less than 10 appointments, this number being a
pragmatic choice on the grounds that it clusters around
the six sessions commonly offered in primary care in the
UK and is clearly fewer than the 12 - 24 sessions usually
provided in secondary care efficacy trials. Studies of com-
puterized or facilitated self-help [28-30], of psycho-edu-
cational groups [31,32], and of psychological therapy
carried out as part of or referral on from case manage-
ment within collaborative care [33], were excluded.
Data extraction
D a t a  f r o m  i n c l u d e d  s t u d i e s  w e r e  e x t r a c t e d  i n t o  s t r u c -
tured summary tables. Studies were classified according
to type of psychological therapy and whether patients
included had major depressive disorder (MDD), minor
depression, mixed depression, anxiety or 'mixed anxiety
and depression' (where participants with a range of diag-
noses of anxiety, depression, unspecified common mental
health problems or 'emotional distress' were included).
Outcome da ta closest to 4 months from baseline were
extracted where there was more than one follow-up
period, as this was the most common follow-up interval
used in our initial set of studies. Other information
extracted included: details of the participants; study
country; length of follow-up (weeks from baseline); num-
ber of treatment sessions; study design (individually ran-
domized or cluster randomized); method of
randomization and allocation concealment; use of inten-
tion-to-treat analysis; primary symptom outcome mea-
sure(s); data of publication; number of participants
randomized and attrition from each group. The data were
initially extracted by one reviewer, with the results being
checked by a second reviewer who extracted the outcome
data independently, but otherwise was not blinded to the
findings of the first reviewer. Disagreements between
reviewers were resolved by discussion.
The quality of each study was assessed by one reviewer
who examined the adequacy of randomization and allo-
cation concealment, and attrition using a modified ver-
sion of the SIGN quality checklist for randomized
controlled trials [34]. A second reviewer, blinded to the
findings of the first reviewer, checked a sample of papers
for reliability of the quality assessment.
Meta-analysis
Comprehensive meta analysis (CMA) software, Version
2.2.040 [35] was used to calculate the standardized mean
difference (d) and associated standard error for each
study, computed from means and standard deviations
(adjusted for baseline differences if reported) or from the
sample size and P-value from an appropriate between-
groups t- or F-test if no other data were reported. W e
used data from an intention-to-treat analysis, with last
observation carried forward, rather than data from par-
ticipants who completed the study, if both were reported.
Where a study only reported data from dichotomous out-
comes (remission or response to treatment), we assumed
t h a t  p a r t i c i p a n t s  w h o  c e a s e d  t o  e n g a g e  i n  t h e  s t u d y  -
from whatever group - had an unfavourable outcome,
then converted the log odds ratio into d using CMA. For
the purposes of the review, negative values of d indicate
that the outcome favoured the intervention. The metan
command in Stata Version 9.2 [36] was used to produce
forest plots and summary effects using a random-effects
model.
We used I2 and the Q test of heterogeneity [37,38] to
examine among-study variation in the meta-analysis. Sig-
nificant variation was confirmed by visual inspection of
the forest plots. I2 describes the proportion of total varia-Cape et al. BMC Medicine 2010, 8:38
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tion in study effect sizes that is due to heterogeneity as
opposed to sampling error, with 25%, 50% and 75% indi-
cating low, moderate and high heterogeneity [38].
We conducted planned sub-group analyses based on
both type of psychological therapy and diagnosis. Sensi-
tivity analyses were used to examine how robust these
f i n d i n g s  w e r e  t o  a s s u m p t i o n s  m a d e  w h e n  c a l c u l a t i n g
effect size.
To check for publication bias, CMA was used to gener-
ate funnel plots and Egger's regression asymmetry test
[39]. Where asymmetry was detected, we assessed the
potential impact of the publication bias using the Duval
and Tweedie nonparametric 'trim and fill' method [40].
This method recalculates the effect size given the pres-
ence of publication bias.
Meta-regression
We used the metareg command in Stata, to conduct ran-
dom-effects meta-regression analyses with restricted
maximum likelihood estimation and the improved vari-
ance estimator of Knapp and Hartung [41]. Where data
allowed, univariate models were used to examine whether
there were differences between psychological therapies
and between diagnostic categories in the magnitude of
the treatment effect. In addition, where possible, we used
multivariate models to control for the following study
characteristics if they were shown to be potential moder-
ators in univariate models: country; year of publication;
number of sessions; total number of participants ran-
domized; type of data (continuous versus dichotomous);
allocation concealment; use of intention-to-treat analysis;
and attrition. In our analyses, the regression coefficients
are the estimated change in d per unit change in each
covariate.
Results
The flowchart outlining the search process is shown in
F i g u r e  1 .  I t  s h o u l d  b e  n o t e d  t h a t  t h i s  r e p r e s e n t s  t h e
entirety of the search, of which only a proportion related
to psychological therapies in primary care. Thirty-four
studies met our inclusion criteria. There were four stud-
ies excluded on basis of the psychological therapy being
10 sessions or more [42-45].
Details of the included studies are given in Table 1.
Twelve were of cognitive behaviour therapy (CBT) [46-
57], seven of counselling [58-64], one of interpersonal
psychotherapy [65], one of psychodynamic psychother-
apy [66] and 12 of problem solving therapy (PST) [67-78].
One study included both a CBT and a counselling inter-
vention arm compared to a usual GP treatment control
[27] and so in the meta-analysis the control group was
halved to avoid double counting.
Of the 34 studies, 14 were of patients with depression
(six MDD, four minor depression, four mixed depres-
sion), seven were of anxiety disorders (three generalized
anxiety disorder, three panic disorder, one mixed phobic
disorders) and 13 studies were of patients with 'mixed
anxiety and depression' (including patients with a range
of diagnoses of anxiety, depression and unspecified com-
mon mental health problems).
Twenty-two of the 34 studies were carried out in UK
primary care, five in the USA, two in the Netherlands,
two in Australia, one in Sweden, one in Taiwan and one
w a s  a  m u l t i - s i t e  s t u d y  i n  f i v e  E u r o p e a n  c o u n t r i e s .  A l l
studies were randomized by the individual participant.
Seven studies were published in the 1980s, 13 in the
1990s and 14 in the present decade. In 14 studies the psy-
chological therapy was conducted in the patients' usual
general practice or primary care clinic location, in two
studies over the telephone, in three studies at home, in
four studies both at home and in other primary care set-
tings and in 11 studies the psychological therapy was
described as being carried out 'in a primary care setting',
'in a local health centre' or 'in primary care' without this
being further specified. The control condition for all
studies was usual GP care, supplemented in a few studies
[49-51,56,67,75,78] by the patient receiving some addi-
tional control intervention, for example placebo medica-
tion or a self-help booklet.
There was similar median treatment intensity of six to
seven contacts with the patient in CBT, counselling and
PST, with the single studies of interpersonal psychother-
apy and psychodynamic psychotherapy each involving
eight sessions of treatment. In terms of the length of fol-
low up, there was some variation between psychological
therapies (median 14 weeks for counselling, 13 weeks for
CBT, and 12 weeks for PST) and also between the CBT
for anxiety (12 weeks) and the CBT for depression studies
(16 weeks).
Table 1 also gives details of the quality assessment of
each study. The method of randomization was well cov-
e r e d  ( 1 5 %  o f  s t u d i e s )  o r  a d e q u a t e l y  a d d r e s s e d  ( 8 5 % ) .
Allocation concealment was unclear (71%) in most stud-
ies. Sixteen (47%) studies were analysed by intention-to-
treat (ITT), with the remainder either not using ITT anal-
ysis or this being unclear in the reported paper. Twenty-
one (62%) studies reported less than 20% attrition across
both groups with eight studies (24%) reporting no attri-
tion. In two studies [62,70] there was 50% or more attri-
tion from either group.
Effect size of psychological therapies
The meta-analysis showed small effects favouring brief
CBT over usual GP care for both depression [d -0.33, 95%
confidence interval (CI) -0.60 to -0.06, k = 4, n = 450) and
mixed anxiety and depression (d -0.26, 95% CI -0.44 to -
0.08, k = 2, n = 479) and a larger effect for brief CBT for
anxiety disorders (anxiety d -1.06, 95% CI -1.31 to -0.80, kCape et al. BMC Medicine 2010, 8:38
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= 7, n = 450; Figure 2). In each meta-analysis, heterogene-
ity between studies was low (CBT for depression I2 = 0%,
Q = 1.72, P = 0.63; CBT for mixed anxiety and depression
I2 = 0%, Q = 0.05, P =.83; CBT for anxiety I2 = 15%, Q =
7.07, P = 0.32).
The meta-analysis suggested counselling was effective
for mixed anxiety and depression (d -0.30, 95% CI -0.53
to -0.07, k = 4, n = 487), while the effect size for counsel-
ling for depression, although similar in size, fell short of
statistical significance (d -0.41, 95% CI -0.84 to 0.03, k = 4,
n = 359; Figure 3). Heterogeneity between studies was
moderate to high for the studies of depression (I2 = 63%,
Q = 8.15, P = 0.04) and low for mixed anxiety and depres-
sion (I2 = 31%, Q = 4.37, P = 0.22). There were no studies
of counselling for anxiety disorders. Pooling across the
studies of depression and mixed anxiety and depression,
heterogeneity was intermediate (I2 = 44%, Q = 12.55, P =
0.04), with a small effect favouring counselling over usual
GP care (d -0.32, 95% CI -0.52 to -0.11, k = 8, n = 846).
The effect size was smaller for PST for both depression
(d -0.26, 95% CI -0.49 to -0.03, k = 5, n = 777) and mixed
anxiety and depression (d -0.17, 95% CI -0.41 to -0.07, k =
6,  n  = 579; Figure 4). Heterogeneity between studies
approached moderate for the studies of depression (I2 =
45%, Q = 9.11, P = 0.11) and was moderate for mixed anx-
iety and depression (I2 = 50%, Q = 10.01, P = 0.08). There
were no studies of PST for anxiety disorders. Pooling
across all studies produced a small effect favouring PST
over usual GP care (d -0.21, 95% CI -0.37 to -0.05, k = 12,
n  = 1356) with heterogeneity approaching a moderate
level (I2 = 45%, Q = 19.88, p = 0.05).
The evidence for interpersonal psychotherapy (d -0.11,
-0.47 to 0.24, k = 1, n = 120) and psychodynamic psycho-
therapy (d -0.01, 95% CI = -0.64 to 0.63, k = 1, n = 38) was
inconclusive, although only one small study was included
for each of these in this review.
For the studies of depression and mixed anxiety and
depression, a series of random-effects meta-regressions
comparing types of psychological therapy, controlling for
diagnosis, indicated there was no difference between
CBT (k = 6) and counselling (k = 8; regression coefficient
-0.02, P =.91, adjusted R2 = 0%, n = 1584) or between CBT
(k = 6) and PST (k = 12) (regression coefficient 0.10, P =
0.45, adjusted R2 = 0%, n = 2094) or between counselling
(k = 8) and PST (k = 12) (regression coefficient 0.10, P =
0.46, adjusted R2 = 0%, n = 2202).
Impact of diagnosis
We conducted two sets of meta-regression analyses to
explore the effect of diagnosis on the magnitude of the
Figure 1 Results of literature searches and selection of randomized controlled trials for inclusion in the meta-analyses.
Potentially relevant references identified and screened for retrieval (n=38000)
Excluded on the basis of title and abstract 
because clearly not relevant (n=37241)
References retrieved for more detailed evaluation (n=759)
Excluded (n=721):  
Not meeting inclusion criteria (n=705) 
Further reports of an included study (n=16) 
Studies of psychological therapies in primary care (n=38)
Excluded as psychological therapy was ten 
sessions or more (n=4) 
Included studies (n=34)C
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Table 1: Details of included studies
Study name Study characteristics Quality assessment
Tx Country Diag Outcome No. sessions Type of data FU (weeks) Total N Rand. AC ITT % attrition (Intv) % attrition (Ctl)
Barrett 2001 [67] PST USA Dep - minor or dys HDRS < 7 6 D 11 161 WC WC Y 18 16
Boot 1994 [58] COU UK Mixed Anx and Dep GHQ 6 C 6 192 AA U N 46 40
Brodaty 1983 [66] PP AUS Mixed Anx and Dep GHQ 8 C 8 78 AA U N 65 26
Catalan 1991 [68] PST UK Mixed Anx and Dep PSE 4 C 11 47 AA U N 0 0
Dowrick 2000 [69] PST EU Dep - MDD or dys BDI 6 C 26 317 AA WC Y 23 26
Earll 1982 [46] CBT UK Mixed Anx and Dep DSSI/sAD * 7.7 D 32 50 AA U N 16**
Friedli 1997 [59] COU UK Mixed Anx and Dep BDI 9 C 12 136 AA AA Y 16 23
Harvey 1998 [60] COU UK Mixed Anx and Dep HADS 6 C 16 162 AA U Y 31 25
Hemmings 1997 
[61]
COU UK Mixed Anx and Dep MHSI 5.7 C 16 188 AA U N 16 23
Holden 1989 [62] COU UK Dep - MDD RDC 8 D 12 50 AA U N 0 0
Kendrick 2005 [70] PST UK Mixed Anx and Dep CIS-R 6 C 26 168 WC WC Y 20 † 31†
Lang 2006 [71] PST USA Mixed Anx and Dep BSI-D 4 C 12 62 AA U Y 34 17
Lindsay 1987 [47] CBT UK Anx - GAD GHQ-28 8 C 4 20 AA U N 0 0
Liu 2007 [72] PST TA Mixed Anx and Dep CIS-R 2.27 C 16 169 WC AA Y 25 22
Lynch 1997 [73] PST USA Dep - minor HDRS 6 C 7 29 AA U N 27 7
Lynch 2004 [74] PST USA Dep - minor HDRS 6 C 6 36 AA U N 50 28
Marks 1985 [48] CBT UK Anx - phobic PS 6 C 26 92 AA U N 37 20
Mynors-Wallis 
1995 [75]
PST UK Dep - MDD HDRS 6 C 12 55 AA U Y 0 0
Mynors-Wallis 
1997 [76]
PST UK Mixed Anx and Dep CIS 4.5 C 26 70 AA AA N 20 13
Power 1989 [49] CBT UK Anx - GAD HAM-A 4 C 6 21 AA U Y 0 0
Power 1990 [51] CBT UK Anx - GAD CGI = 1 7 D 10 79 AA U N 0 0
Power 2000 [50] CBT UK Anx - panic HAM-A 6 C 12 72 AA U N 16 17
Prendegast 2001 
[52]
CBT AUS Dep - mixed EPDS < 10 6 D 26 37 AA U N 0 0
Robson 1984 [53] CBT UK Mixed Anx and Dep PS 3.7 C 14 429 AA U N 0 †† 0 ††C
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Schreuders 2007 
[77]
PST NL Mixed Anx and Dep HADS 6 C 12 175 AA WC N 30 22
Scott 1992 [54] CBT UK Dep - MDD HDRS 9.8 C 16 60 AA AA Y 3 3
Scott 1997 [55] CBT UK Dep - MDD HDRS 6 C 7 48 AA U N 25 33
Sharp 1996 [56] CBT UK Anx - panic HAM-A ‡ 7 D 13 154 AA U Y 21§ 24§
Sharp 2004 [57] CBT UK Anx - panic HAM-A 8 C 12 59 AA U Y 16 14
Simpson 2003 [63] COU UK Dep - mixed BDI 5 C 26 145 AA U Y 11 10
Van Schaik 2006 
[65]
IPT NL Dep - MDD MADRS 8 C 26 143 WC WC Y 16 16
Ward 2000 [27] CBT  UK Dep - mixed BDI 5 C 16 197 AA U Y 11 8
COU 6.4 8
Wickberg 1996 
[64]
COU SW Dep - mixed MADRS ¶ 6 D 7 45 AA U N 0 0
Williams 2000 [78] PST USA Dep - minor or dys HDRS < 7 6 D 11 278 WC AA Y 18§ 15§
* Patients were categorized as not 'personally ill' by study authors.
** Number randomized to each group not reported by study authors.
† We used missing data that were imputed from a regression analysis that took account of the baseline information for each participant with missing data rather than from last observation carried 
forward because of differential attrition between study groups.
†† Attrition not reported by study authors; therefore we assumed there was no missing data.
‡ Study authors defined response as a clinically significant change.
§ For the purposes of the meta-analysis, participants with missing data were assumed to have had a poor outcome.
¶ Study authors defined response as a substantial improvement.
AA, adequately addressed; AC, allocation concealment; AUS, Australia; Anx, anxiety; BDI, Beck Depression Inventory; BSI-D, Brief Symptom Inventory - Depression scale; C, continuous; CBT, cognitive 
behavioural therapy; CES-D, Center for Epidemiologic Studies Depression Scale; CGI, Clinical Global Impression; CIS-R, Clinical Interview Schedule - Revised; COU, Counselling; Ctl, control; D, 
dichotomous; Dep, depression; Dep - mixed, mixed depressive diagnoses including minor depression; Diag, diagnosis; DSSI/sAD, Delusions-Symptoms-States Inventory/states of Anxiety and 
Depression; dys, dysthymia; EPDS, Edinburgh Postnatal Depression Scale; EU, European countries; GHQ, General Health Questionnaire; HADS, Hospital Anxiety and Depression Scale; HAM-A, 
Hamilton Anxiety Rating Scale; HDRS, Hamilton Depression Rating Scale; Intv, intervention; IPT, Interpersonal psychotherapy; ITT, intention-to-treat analysis; MADRS, Montgomery-Åsberg 
Depression Rating Scale; MDD, major depressive disorder; MHSI, Mental Health Symptom index;; Mixed Anx and Dep, mixed anxiety and depression diagnoses; N, number randomized; NL, 
Netherlands; PP, Psychodynamic psychotherapy; PS, psychiatric symptoms; PSE, Present State Examination; PST, problem solving therapy; Rand., randomization; RDC, Research Diagnostic Criteria; 
SW, Sweden; TA, Taiwan; Tx, treatment; U, unclear; WC, well covered; Y, yes.
Table 1: Details of included studies (Continued)Cape et al. BMC Medicine 2010, 8:38
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treatment effect. First, we looked at whether there was a
difference between studies of anxiety, depression and
mixed disorders in the 13 studies of CBT (Figure 2; Table
2). This analysis was limited to studies of CBT as all stud-
ies of anxiety disorders were of CBT. The results indicate
that there was a statistically significant difference favour-
ing the studies of anxiety (k = 7) over depression (k = 4;
regression coefficient 0.72, P = 0.005, adjusted R2 = 91%, n
= 709). There was also a significant difference favouring
the studies of anxiety (k  = 7) over mixed anxiety and
depression (k = 2; regression coefficient 0.79, P = 0.003,
adjusted  R2 = 94%, n  = 929). There was no difference
between the studies of depression (k = 4) and mixed anxi-
ety and depression (k = 2; regression coefficient 0.07, P =
0.70, adjusted R2 = 0%, n = 738). In accordance with our
planned analytic strategy, as no study characteristic other
than diagnosis predicted effect size of CBT studies in the
univariate models (Table 2), we did not use a multivariate
meta-regression model.
Translating the effect sizes for CBT for anxiety and
depression into Hamilton rating scale equivalents to give
an indicator of clinical significance [using all studies in
the database to estimate the Hamilton standard devia-
tions], the effect size for CBT for depression was equiva-
l e n t  t o  a  2 . 3  p o i n t  d i f f e r e n c e  b e t w e e n  g r o u p s  o n  t h e
Hamilton Rating Scale for Depression [79] while the
effect size for CBT for anxiety was equivalent to 7.2
points on the Hamilton Rating Scale for Anxiety [80].
In the second set of meta-regressions, we examined
whether the type of depression diagnosis had an impact
on the treatment effect across types of psychological
therapy. The results indicate that there was no significant
Figure 2 Brief cognitive behaviour therapy versus usual general practitioner care, sub-grouped by diagnosis.
NOTE: Weights are from random effects analysis
.
.
.
Anxiety
Lindsay et al. (1987)
Marks (1985)
Power et al. (1989)
Power et al. (1990)
Power et al. (2000)
Sharp et al. (1996)
Sharp et al. (2004)
Subtotal  (I-squared = 15.1%, p = 0.315)
Depression
Prendegast & Austin (2001)
Scott & Freeman (1992)
Scott et al. (1997)
Ward et al. (2000)a
Subtotal  (I-squared = 0.0%, p = 0.632)
Mixed anxiety & depression
Earll & Kincy (1982)
Robson et al. (1984)
Subtotal  (I-squared = 0.0%, p = 0.827)
ID
Study
-1.36 (-2.33, -0.39)
-0.66 (-1.16, -0.16)
-1.46 (-2.42, -0.50)
-1.15 (-1.88, -0.41)
-1.22 (-1.77, -0.67)
-0.81 (-1.24, -0.38)
-1.51 (-2.16, -0.87)
-1.06 (-1.31, -0.80)
-0.37 (-1.06, 0.32)
-0.04 (-0.56, 0.47)
-0.50 (-1.18, 0.19)
-0.45 (-0.87, -0.02)
-0.33 (-0.60, -0.06)
-0.19 (-0.83, 0.45)
-0.27 (-0.46, -0.08)
-0.26 (-0.44, -0.08)
d (95% CI)
6.38
20.38
6.49
10.58
17.36
25.40
13.41
100.00
15.49
27.91
15.83
40.77
100.00
8.11
91.89
100.00
Weight
%
20
66
21
79
60
154
50
37
58
34
130
50
429
N
Total
-1.36 (-2.33, -0.39)
-0.66 (-1.16, -0.16)
-1.46 (-2.42, -0.50)
-1.15 (-1.88, -0.41)
-1.22 (-1.77, -0.67)
-0.81 (-1.24, -0.38)
-1.51 (-2.16, -0.87)
-1.06 (-1.31, -0.80)
-0.37 (-1.06, 0.32)
-0.04 (-0.56, 0.47)
-0.50 (-1.18, 0.19)
-0.45 (-0.87, -0.02)
-0.33 (-0.60, -0.06)
-0.19 (-0.83, 0.45)
-0.27 (-0.46, -0.08)
-0.26 (-0.44, -0.08)
d (95% CI)
6.38
20.38
6.49
10.58
17.36
25.40
13.41
100.00
15.49
27.91
15.83
40.77
100.00
8.11
91.89
100.00
Weight
%
Favours treatment   Favours control 
0 -2 -1 0 1 2Cape et al. BMC Medicine 2010, 8:38
http://www.biomedcentral.com/1741-7015/8/38
Page 8 of 13
difference between MDD (k = 6) and minor depression/
mixed depression (k = 9; regression coefficient 0.12, P =
0.43, adjusted R2 = 2%, n  = 1515), or between minor
depression (k = 4) and MDD/mixed depression (k = 11;
regression coefficient -0.20, P = 0.22, adjusted R2 = 25%, n
= 1515). No other study characteristic predicted effect
size of the depression studies, so no multivariate meta-
regression was used.
Publication bias
Funnel plots of the CBT studies, showed evidence of
asymmetry in the studies of CBT for anxiety (Egger's test,
one-tailed P = 0.04), but not CBT for depression/mixed
anxiety and depression (P = 0.38). There was also evi-
dence of asymmetry in the studies of counselling (one-
tailed P = 0.03) and PST (one-tailed P = 0.03). The Duval
and Tweedie 'trim and fill' method suggested that, for
CBT for anxiety, three studies were potentially missing
and, if imputed, the overall summary effect would drop to
d -0.91 (95% CI -1.18 to -0.63). For counselling, imputing
three missing studies reduced the effect size to d -0.19
(95% CI -0.41 to -0.04). For PST, imputing two missing
studies reduced the effect size to d -0.14 (95% CI -0.32 to
-0.05).
Discussion
Summary of main findings
The majority of studies of brief psychological therapies
for anxiety and depression in primary care included in
this review were of CBT, counselling and PST, with a sin-
gle study each of interpersonal psychotherapy and of psy-
chodynamic psychotherapy. The meta-analysis suggests
that brief CBT, counselling and PST were all effective. No
significant difference was found between CBT, counsel-
ling and PST on meta-regression, when controlling for
diagnosis,
Brief CBT for anxiety (mostly generalized anxiety dis-
order and panic disorder) had a greater impact on clinical
outcomes than brief CBT for depression or of mixed
groups of patients with common mental health problems,
Figure 3 Brief counselling versus usual general practitioner care, sub-grouped by diagnosis.
NOTE: Weights are from random effects analysis
.
.
Overall  (I-squared = 44.2%, p = 0.084)
Subtotal  (I-squared = 31.4%, p = 0.224)
Boot et al. (1994 )
Ward et al. (2000)b
Friedli et al. (1997)
Wickberg & Hwang (1996)
Mixed anxiety & depression
Simpson et al. (2003)
Harvey et al. (1998)
Subtotal  (I-squared = 63.2%, p = 0.043)
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0.06 (-0.29, 0.40)
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d (95% CI)
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for which the outcomes were similar to studies of coun-
selling and of low clinical significance. There were no
studies of counselling or PST for anxiety disorders alone,
so it is not possible to establish from this review whether
this is a specific differential effect of CBT or whether
other brief psychological therapies might also have
greater effects on anxiety than depression.
Comparison with existing literature
Reviews of CBT have generally found larger effect sizes
compared to control for CBT as a treatment for anxiety
disorders, with smaller effects obtained for CBT as a
treatment for depression [12]. This is similar to the differ-
ential effect for brief CBT found in the present review. A
r e c e n t  r e v i e w  o f  i n t e r n e t - b a s e d  C B T  o f  a n x i e t y  a n d
depression, also found differential effects between studies
of internet-based CBT on depression and studies of inter-
net-based CBT on anxiety [81], with remarkably similar
effect sizes (d 0.27 depression, d 0.93 anxiety) to those in
the present review (d 0.33 depression, d 1.06 anxiety).
The summary effects obtained were generally lower
than reviews of secondary care based treatments, involv-
ing a longer duration of psychological therapies
[10,12,82]. These differences in effect size could be due to
a number of factors: length of treatment, type of included
patients, training of therapists or location of treatment. In
terms of type of included patients, participants in these
primary care based studies may have had less severe con-
ditions than those in secondary care based studies which
would correspondingly limit the potential effect sizes.
Brief CBT for anxiety disorders was the exception, with
effect sizes in the present review comparable to those
obtained in reviews of longer secondary care based treat-
ments [12,13]. This may not be unique to primary care. In
Figure 4 Brief problem solving therapy versus usual general practitioner care, sub-grouped by diagnosis.
NOTE: Weights are from random effects analysis
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Table 2: Results of univariate meta-regressions for the 13 studies of cognitive behaviour therapy
Variable Category 1 (k; N)C a t e g o r y  2  ( k; N) Regression
coefficient
Standard
error
95% CI P* I2 Adj R2
Dichotomous
Diagnosis 
(model a)
Anxiety = 0 (7; 497) Depression = 1 (4; 275) .72 .20 .28-1.16 .005 0% 91%
Diagnosis 
(model b)
Anxiety = 0 (7; 497) Mixed anxiety & 
depression = 1 (2, 479)
.80 .18 .36-1.23 .003 2% 94%
Diagnosis 
(model c)
Depression = 0 (4; 275) Mixed anxiety & 
depression = 1 (2; 479)
.07 .17 -.39-.53 .70 0% 0%
Country UK = 0 (12; 1214) Other = 1 (1; 37) .36 .56 -.87-1.58 1.00 71% 0%
Type of data Continuous = 0 (9; 931) Dichotomous = 1 (4; 320) -.11 .31 -.79-.58 1.00 70% 0%
Continuous Range (k; N)
Number of 
sessions
3.7-9.8 (13; 1251) -.03 .08 -.21-.15 1.00 65% 0%
Follow up 
(weeks)
4-31.6 (13; 1251) .03 .02 -.003-.07 .46 67% 22%
Year of 
publication
1982-2004 (13; 1251) -.02 .02 -.06-.02 .89 59% 16%
Number 
randomized
20-429 (13; 1251) .001 .001 -.001-.004 .89 59% 7%
Attrition 
(intervention 
group)
0-37% (13; 1251) -.01 .01 -.03-.02 1.00 67% 0%
Attrition 
(control group)
0-33% (13; 1251) -.01 .01 -.04-.03 1.00 67% 0%
Study quality 1-4 (13, 1251) .16 .22 -.31-.64 1.00 71% 0%
*P-values are adjusted for multiple testing, calculated using the Higgins and Thompson Monte Carlo permutation test (10,000 permutations), 
except for the diagnostic variables which are unadjusted.
Adj R2 = adjusted R2 (proportion of between-study variance explained by the covariate); k = number of studies; N = total sample size.
secondary care, a direct comparison of brief and standard
length CBT for panic disorder found equivalent effective-
ness [83].
Strengths and limitations of the study
The strengths of the review are the inclusion of studies of
representative populations of primary care patients,
including with mixed anxiety and depression, and the use
of meta-regression to compare effectiveness between dif-
ferent types of problems and different types of psycholog-
ical therapy.
Limitations are the restriction to published studies and
to English language publications. Other relevant studies
may have been missed, particularly negative studies lead-
ing to an overestimation of the effects of brief psychologi-
c a l  t h e r a p i e s .  W e  d i d  f i n d  e v i d e n c e  o f  p o s s i b l e
publication bias and that accounting for this would have
reduced effect sizes, although not changed the key con-
clusions of the review. Type of outcome measures, num-
ber of treatment sessions, follow-up intervals, country,
number of participants randomized and aspects of study
quality varied between studies, increasing heterogeneity
and, hence, decreasing the likelihood of finding differ-
ences between types of psychological therapy and differ-
ent diagnoses. Meta-regression ideally requires large
numbers of studies and the sample size of studies in the
review may have been too small to show other than rela-
tively large effect size differences between types of psy-
chological therapy.
The majority of studies in the meta-analysis used ques-
tionnaires and rating scales as outcome measures.
Although this is standard in measurement of depression
and anxiety outcomes, responses to such measures can
vary between gender, language, culture and setting and
are only a proxy for diagnosis. When analysed as continu-
ous measures, there are potential problems caused by
lack of interval-scaling, which may result in a sigmoidal,
rather than linear, relationship between the score and the
underlying trait [84]. Dependence on such measures in
the meta-analysis is likely to have increased measurement
error and heterogeneity [85]. They may also have led to
systematic biases in the meta-regression where groupsCape et al. BMC Medicine 2010, 8:38
http://www.biomedcentral.com/1741-7015/8/38
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being compared (for example, patients with MDD versus
minor and mixed depression) were using different mea-
sures or had baseline differences on the same measure.
A further limitation is the likely variation in locations
included as 'primary care'. Reviews of psychological ther-
apies in primary care vary in definitions as to what is
included as primary care, with some reviews including
studies if patients are recruited in or referred from pri-
mary care irrespective of where patients are treated. We
set out to include studies where patients were treated
either in a primary care setting or at home organized
from primary care, but many study reports lacked details
of where patients were seen other than 'in a primary care
setting'. The significance of treatment in primary care is
considered to be familiarity and accessibility of location
and ease of liaison between GP and treating psychological
therapist but this will quite probably have varied widely,
given that studies varied from only one or two patients
treated per participating general practice [55,56,75], to a
few hundred [53]. Better reporting of location of treat-
ment and nature of liaison with patients' GPs should be
encouraged in studies of treatment in primary care.
Conclusions
This review confirms the effectiveness of brief CBT,
counselling and PST for routine delivery in primary care
but with the caution that effect sizes are low when com-
pared to patients receiving these treatments over a longer
duration, so for many patients brief treatments may not
be sufficient. The exception is brief CBT for anxiety dis-
orders, which was comparable in effectiveness to longer
treatments. While this suggests that brief CBT is particu-
larly effective with anxiety disorders and there is evidence
that training in CBT may enhance effectiveness of treat-
ment of anxiety disorders by counsellors [86], the lack of
randomized studies of brief psychological therapies other
than CBT for patients suffering from anxiety disorders
means that it is not possible to definitively determine
whether brief CBT is more effective than other brief psy-
chological treatments for anxiety disorders within pri-
mary care.
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